Role of the Timed Up and Go Test in Patients With Chronic Obstructive Pulmonary Disease

Haddad, Maath Al; John, Michelle; Hussain, Samia; Bolton, Charlotte E.

doi:10.1097/hcr.0000000000000143

Cited by 42 publications

(52 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, these studies (9,23,27,30) contribute to strengthening our argument for the use of field tests and their clinical relevance to detect damage to the mobility and functionality of individuals. We also emphasize that while reductions in muscle strength and functionality are simultaneous, as a result of the aging process, reduced functional capacity may be detected before, as suggested by Akbari e Mousavikhatir (12), and tests, such as the 10m walking test, TUG and ISWT may be used to screen for the purpose of discriminating individuals at risk (9).…”

Section: Discussionmentioning

confidence: 99%

Test timed up and go and its correlation with age and functional exercise capacity in asymptomatic women

et al. 2017

View full text Add to dashboard Cite

Introduction:The Timed Up and Go test (TUG) is widely used and valid in chronic patients, but rarely addressed in asymptomatic individuals. Objective: To assess the reliability, the age-related changes and the correlation between TUG and the Functional Exercise Capacity (FEC) adjusted for non-institutionalized middle-aged and elderly women. Methods: Ninety-eight women (57 ± 10 years) were selected and stratified into age groups. We have performed the tests TUG, Berg Balance Scale (BBS) and evaluation of usual gait speed (UGS). Fifty-eight participants (57 ± 10 years) also performed incremental shuttle walk test (ISWT). Results: Worse performance in TUG (p < 0,05) for participants aged ≥ 70 years for age groups 40-49 and 50-59 years. The reliability of TUG was excellent between the first and second TUG (intraclass correlation coefficient, 0.933; confidence interval of 95%, from 0.901 to 0.955) and between the second and third TUG (0.958, 0.938 to 0.972). The group of 58 participants who underwent further the ISWT, TUG correlated significantly (p <0.05) with ISWT (r = -0.72), VUM (r = -0.54) and BBS (r= 0.58). A multiple linear regression analysis selected TUG (R 2 = 0.517) and VUM (R 2 = 0.083) as determinants of FEC. Conclusion: TUG adapted

show abstract

Section: Discussionmentioning

confidence: 99%

Test timed up and go and its correlation with age and functional exercise capacity in asymptomatic women

et al. 2017

View full text Add to dashboard Cite

show abstract

“…In COPD patients, an optimal test should be targeted for each case. For instance, the TUG test has not been associated with airflow limitation, in contrast to the 6-min walk distance [65]. Therefore, the TUG test could be implemented in cases of COPD with more severe ventilatory impairment.…”

Section: Sarcopenia Consensus Statementsmentioning

confidence: 99%

Sarcopenia in COPD: a systematic review and meta-analysis

et al. 2019

View full text Add to dashboard Cite

COPD is associated with a progressive loss of muscle mass and function. However, there is an unmet need to define and standardise methods to estimate the prevalence of sarcopenia in COPD patients.We performed a systematic review and meta-analysis of the prevalence of this extrapulmonary manifestation in COPD patients. We searched Embase, Medline (Ovid), CINAHL (EBSCO), Web of Science, Scopus and Google Scholar for studies published up to January 17, 2019, assessing sarcopenia in COPD patients based on low muscle mass and decreased muscle function. Interventional studies, in vitro experiments, protocols or reviews and meta-analyses were excluded. We estimated heterogeneity (I2) and assessed significance (Q) using a Chi-squared test for estimates obtained from random-effects models.4465 articles were initially identified. After removing the duplicates and applying the selection criteria, we reviewed 62 full-text articles. Finally, 10 articles (n=2565 COPD patients) were included in this systematic review and meta-analyses. Overall, the prevalence of sarcopenia in patients with COPD was 21.6% (95% CI 14.6–30.9%, I2=94%), ranging from 8% in population-based to 21% in clinic-based studies, and 63% in COPD patients residing in nursing homes.Sarcopenia is frequently observed in COPD patients, with varying prevalence across population settings. Sarcopenia in COPD should be assessed using standardised tests and cut-off points from sarcopenia consensus criteria for clinical practice and international comparisons.

show abstract

“…The TUG-test has been widely cited in the literature as an outcome measure in a variety of conditions influencing mobility including stroke [7], chronic obstructive pulmonary disease [8] and Parkinson's disease [9]. Moreover, TUG has been recommended for assessment of walking and balance in guidelines for fall prevention [10].…”

Section: Introductionmentioning

confidence: 99%

Remote timed up and go evaluation from activities of daily living reveals changing mobility after surgery

et al. 2019

View full text Add to dashboard Cite

Background. Mobility impairment is common in older adults and negatively influences the quality of life. Mobility level may change rapidly following surgery or hospitalization in the elderly. The Timed Up and Go (TUG) is a simple, frequently used clinical test for functional mobility; however, TUG requires supervision from a trained clinician, resulting in infrequent assessments. Additionally, assessment by TUG in clinic settings may not be completely representative of the individual's mobility in their home environment. Objective. In this paper, we introduce a method to estimate TUG from activities detected in free-living, enabling continuous remote mobility monitoring without expert supervision. The method is used to monitor changes in mobility following Total Hip Arthroplasty (THA). Methods. Community-living elderly (n=239, 65-91 years) performed a standardized TUG in a laboratory and wore a wearable pendant device that recorded accelerometer and barometric sensor data for at least 3-days. Activities of daily living, including walks and sit-to-stand transitions, and their related mobility features were extracted and used to develop a regularized linear model for remote TUG test estimation. Changes in the remote TUG were evaluated in orthopaedic patients (n=15, 55-75 years), during 12-weeks following THA. Results. In leave-one-out-cross-validation, a strong correlation (ρ=0.70) was observed between the new remote TUG and standardized TUG times. Test-retest reliability of 3-day estimates was high (ICC=0.94). Compared to 2-weeks post-THA, remote TUG was significantly improved at 6-weeks (11.7±3.9 s vs 8.0±1.8 s, p<0.001), with no further change at 12-weeks (8.1±3.9 s, p=0.37). Conclusions. Remote TUG can be estimated in older adults using 3-days of ADLs data recorded using a wearable pendant. Remote TUG has discriminatory potential for identifying frail elderly and may provide a convenient way to monitor changes in mobility in unsupervised settings.

show abstract

Role of the Timed Up and Go Test in Patients With Chronic Obstructive Pulmonary Disease

Cited by 42 publications

References 33 publications

Test timed up and go and its correlation with age and functional exercise capacity in asymptomatic women

Test timed up and go and its correlation with age and functional exercise capacity in asymptomatic women

Sarcopenia in COPD: a systematic review and meta-analysis

Remote timed up and go evaluation from activities of daily living reveals changing mobility after surgery

Contact Info

Product

Resources

About